Open access · US-GOV via ClinicalTrials.gov Clinical trial

Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Authors not listed

H. Lundbeck A/S · 2014

Loss of proteostasis Human Randomized controlled trial

Abstract

To establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-11-01 MST

Cite this

APA

Anonymous. (2014). Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil. <em>H. Lundbeck A/S</em>. https://clinicaltrials.gov/study/NCT02006641

Vancouver

Anonymous. Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil. H. Lundbeck A/S. 2014.

BibTeX

@misc{anon2014Random, title = {Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil}, author = {Anonymous}, journal = {H. Lundbeck A/S}, year = {2014}, }